LENZ Therapeutics (LENZ) Insider Scheiner Buys 22,100 Shares
Zachary Scheiner purchased 22,100 shares of LENZ on June 15, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Zachary Scheiner bought 22,100 shares of LENZ Therapeutics, Inc. ($LENZ) on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $LENZ is down 12.2% after 1 week, down 24.7% after 1 month and down 50.7% to date (from the $6.63 close on Jun 15, 2026).
LENZ
LENZ Therapeutics, Inc.
Key Points
- Zachary Scheiner purchased 22,100 shares of LENZ on June 15, 2026, without a disclosed transaction price.
- Shares of LENZ traded near $6.77, with institutional investors showing mixed activity in recent filings.
- Analysts have varied ratings on LENZ, with Citigroup maintaining a 'buy' and a $20 target on May 13, 2026.
Get $LENZ trade alerts by text
We text you when insiders, Congress or big funds trade $LENZ. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated LENZ Therapeutics, Inc. alert may contain errors. Disclosures
Zachary Scheiner recently bought 22,100 shares of LENZ on June 15, 2026. The transaction was not part of a pre-planned trading program, and no purchase price was disclosed.
Insider Buying and Selling at LENZ Therapeutics, Inc.
On June 15, 2026, several insiders, including Zachary Scheiner, Frederic Guerard, James McCollum, Shelley Thunen, Kimberlee Drapkin, and Jeffrey George, each bought 22,100 shares of LENZ. These transactions were not part of any pre-arranged trading plans, and the details did not specify the purchase price.
Other Institutional Activity in LENZ
Institutional investors have shown varied interest in LENZ. Versant Venture Management, LLC doubled its holdings by adding 2,656,888 shares, ending with 5,313,776 shares valued at about $48.6 million. RA Capital Management, L.P. maintained its position with 4,178,823 shares worth approximately $38.2 million. Alpha Wave Global, LP also held steady, keeping its 3,612,211 shares valued at roughly $33.1 million. FMR LLC slightly reduced its holdings by 104,934 shares, holding 3,597,784 shares valued at around $32.9 million. BlackRock, Inc. increased its stake by 284,817 shares, bringing its total to 1,976,823 shares worth about $18.1 million.
Analysts Set New Price Targets
On May 13, 2026, Citigroup maintained its 'buy' rating on LENZ with a price target of $20. A day earlier, HC Wainwright & Co. also maintained a 'buy' rating, setting a target of $38. Piper Sandler, however, downgraded LENZ to a 'hold' with a $12 target on the same day. The analyst consensus rates the stock as a 'buy', with an average target price reflecting confidence in its potential.
Bottom Line
Zachary Scheiner's recent purchase of LENZ shares might attract attention, though the lack of a disclosed transaction price leaves some questions. Institutional investors and analysts have shown mixed responses, reflecting a range of expectations for the company's performance. As always, insider transactions can provide useful insights, but they are just one piece of a larger puzzle when evaluating a stock.
Related Filing Alerts
Source: Zachary Scheiner's Form 4 filing on $LENZ (Jun 15, 2026). Find the original filing: LENZ Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts